Lyophilisation for Pharmaceuticals Conference

• Dr Stanley M Speaker III, Senior Scientist, Pfizer
• Patrick Carl, Head of Capacity Management Technical Operations, Merck
• Andrew Brown, Department of Systems Research, GlaxoSmithKline
• Lydia Dolezel, Auditor - Computer Systems Quality, Eli Lilly
• Dr Lavinia Lewis, Research Scientist, Pfizer
• Mikael Brülls, R&D Mölndal Development of Lyophilized Formulations, AstraZeneca
• Dr Irina A Antonijevic, Director, Translational Research, H. Lundbeck
• Dr Michael J Akers, Senior Director, Pharmaceutical Research and Development Editor-in-Chief, Baxter
• Mike Schäfers, Director, Scientific & Technical Customer Services Europe/Asia Pacific, West Pharmaceutical Services
• Davide Fissore, Dipartimento di Scienza dei Materiali e Ingegneria Chimica, Politecnico di Torino
  
  
   

Over the last few years, lyophilisation has become a crucial enabling process technology for many important drugs. It has meant that material can be easily stored, shipped and later reconstituted to its original form for injection, and this has brought many new applications and the possibility for reducing costs. If you have not yet taken steps in this direction, or want to improve your current structure to improve your portfolio, then this even is essential for you. Our panel of expert speakers at the 2008 Lyophilisation conference will be on hand to share their knowledge and experience and guarantee your improvement. This exclusive one-off event brings together the leaders in the field - so reserve your place NOW?

The technology offers:
• reduced running costs
• reduced investments
• higher capacity
• higher product quality
• faster process development and scale-up times

PA Consulting maintain that “Anybody comparing this technology to what they live with today will quickly see the advantage of the new process”.

However, freeze-drying is also a complex, costly, and facility-intensive process that many companies do, but only a few do well. By attending this conference, you will find out what steps need to be taken in order to stay competitive, and also to keep on the right side of the regulators.

And with the field of drug discovery now experiencing impressive advancements through maturing technologies, those at the forefront will lead the way in this profitable sector. Reserving a place at this conference will provide a practical approach to help you develop strategies for successful formulation, lyo cycle development and optimisation, validation, and scale-up.

Visiongain’s hotly-anticipated event will enable you to examine the latest technological breakthroughs, discuss and debate scientific processes, share the expert’s opinions on all aspects of lyophilisation, and forge the right partnerships for the coming years.

Key Themes

Enable yourself to implement vacuum technology

Discuss the key impact of the formulation

Evaluate container-closure systems

Understand the selection of a freezing process

Determine of the primary drying parameters

Secondary drying - determination of the end-point

Examine Thermal analytical techniques

Recognise calorimetric monitoring of the lyophilisation process

Find out the impact of the freeze-drying equipment on the lyophilisation process

Learn more about the final product evaluation

Head of Drug Development Strategy

Director of Drug Safety/Risk Management

Head of Project Packaging

VP/Head of Research & Development and Product Safety/Stability Assessment

VP/Head of Patient Safety and Outcomes Research and Data Analysis

VP/Head of Regulatory Affairs and Compliance

To reserve your place, please contact